• OPEN AN ACCOUNT
Indian Indices
Sensex
74,764.23 -813.35
( -1.08%)
Global Indices
Nasdaq
52,820.00 -615.25
(-1.15%)
Dow Jones
7,695.68 -43.92
(-0.57%)
Hang Seng
65,089.68 -179.65
(-0.28%)
Nikkei 225
10,811.26 -10.87
(-0.10%)
Forex
USD-INR
94.51 0.08
(0.08%)
EUR-INR
109.83 0.16
(0.15%)
GBP-INR
127.88 0.26
(0.20%)
JPY-INR
0.61 0.01
(0.93%)

EQUITY - MARKET SCREENER

Novartis India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500672
INE234A01025
331.2308625
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NOVARTIND
46.04
4502
EPS(TTM)
Face Value()
Div & Yield %
39.6
5
1.37
 

greenearth resources & projects ltd
Embassy Developments appoints Neel Virwani as Chief Business Officer
Sep 09,2026
Embassy Developments (EDL)announced the appointment of Neel Virwani as Chief Business Officer, effective 01 October 2026, following the approval of his appointment as Senior Management Personnel by the Company's Board of Directors and shareholders.

A Promoter at Embassy Group and part of its next generation of leadership, Neel has been associated with the Group since April 2024, working across strategic planning, business development, and brand transformation initiatives. He has been instrumental in evaluating new markets and expansion opportunities, while also maintaining close involvement with the Group's family office and investment activities.

The move comes as EDL progresses its growth plans, targeting Rs 6,000 crore in pre-sales from owned developments and Rs 2,000 crore from development management projects in FY27, alongside an 11-project launch pipeline with a GDV of Rs 19,800 crore across key markets.